A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Authors
Keywords
-
Journal
INFLAMMOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-07
DOI
10.1007/s10787-022-01129-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies
- (2022) Hamidreza Zalpoor et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy
- (2022) Mohammad Rafi Khezri et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
- (2022) Steven Chee Loon Lim et al. JAMA Internal Medicine
- Lectins and lectibodies: potential promising antiviral agents
- (2022) Mohsen Nabi-Afjadi et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Quercetin potential effects against SARS‐CoV ‐2 infection and COVID ‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α ( HIF ‐1α)
- (2022) Hamidreza Zalpoor et al. PHYTOTHERAPY RESEARCH
- Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality
- (2022) Hamidreza Zalpoor et al. Human Cell
- Increased neuropilin-1 expression by COVID-19: a possible cause of long-term neurological complications and progression of primary brain tumors
- (2022) Hamidreza Zalpoor et al. Human Cell
- Hypoxia‐inducible factor 1 alpha (HIF‐1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy
- (2022) Hamidreza Zalpoor et al. Human Cell
- Possible role of autophagy induced by COVID-19 in cancer progression, chemo-resistance, and tumor recurrence
- (2022) Hamidreza Zalpoor et al. Infectious Agents and Cancer
- Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways
- (2022) Hamidreza Zalpoor et al. INFLAMMOPHARMACOLOGY
- Hypoalbuminemia in COVID‐19: assessing the hypothesis for underlying pulmonary capillary leakage
- (2021) M. A. Wu et al. JOURNAL OF INTERNAL MEDICINE
- Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
- (2021) Ahmad F. Eweas et al. Frontiers in Microbiology
- Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
- (2021) Vicky Mody et al. Communications Biology
- Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2
- (2021) Fateme Khomari et al. BIOLOGICAL PROCEDURES ONLINE
- Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
- (2021) Eduardo López-Medina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19
- (2021) Hatem Elalfy et al. JOURNAL OF MEDICAL VIROLOGY
- Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
- (2021) Pierre Kory et al. AMERICAN JOURNAL OF THERAPEUTICS
- Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
- (2021) Nurullah Okumuş et al. BMC INFECTIOUS DISEASES
- Effect of ivermectin on COVID-19: A multicenter double-blind randomized controlled clinical trial
- (2021) Leila Shahbaznejad et al. CLINICAL THERAPEUTICS
- Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
- (2021) Abhigyan Choudhury et al. Future Virology
- Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial
- (2021) Reaz Mahmud et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
- (2021) Julio Vallejos et al. BMC INFECTIOUS DISEASES
- Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
- (2021) Navneet Joshi et al. LIFE SCIENCES
- Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon
- (2021) Ali A. Samaha et al. Viruses-Basel
- Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth
- (2021) Shican Zhou et al. Frontiers in Pharmacology
- The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review
- (2021) Asiya Kamber Zaidi et al. JOURNAL OF ANTIBIOTICS
- Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective
- (2021) Shailendra K. Saxena et al. JOURNAL OF MEDICAL VIROLOGY
- Krebs Cycle Reborn in Macrophage Immunometabolism
- (2020) Dylan G. Ryan et al. Annual Review of Immunology
- The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
- (2020) Sundy N.Y. Yang et al. ANTIVIRAL RESEARCH
- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
- (2020) Aiping Wu et al. Cell Host & Microbe
- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
- (2020) David S. Hui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon
- (2020) Andrew A. Beng et al. BMC INFECTIOUS DISEASES
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
- (2020) Qihui Wang et al. CELL
- The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
- (2020) Virginia D. Schmith et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- A global treatments for coronaviruses including COVID‐19
- (2020) Bahman Yousefi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
- (2020) Emanuele Rizzo NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Ivermectin Inhibits Bovine Herpesvirus 1 DNA Polymerase Nuclear Import and Interferes With Viral Replication
- (2020) Sohail Raza et al. Microorganisms
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- A comprehensive review of COVID-19 characteristics
- (2020) Hanie Esakandari et al. BIOLOGICAL PROCEDURES ONLINE
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
- (2020) Fatemeh Heidary et al. JOURNAL OF ANTIBIOTICS
- Attenuated Interferon and Proinflammatory Response in SARS-CoV-2–Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation
- (2020) Dong Yang et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of human adenovirus replication by the importin α/β1 nuclear import inhibitor ivermectin
- (2020) Cason R. King et al. JOURNAL OF VIROLOGY
- In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
- (2020) Julien Andreani et al. MICROBIAL PATHOGENESIS
- Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
- (2020) Han Zhong et al. PHARMACOLOGICAL RESEARCH
- Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse
- (2020) Luiz G. Gardinassi et al. Frontiers in Immunology
- In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
- (2020) Andrés Pizzorno et al. ANTIVIRAL RESEARCH
- Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study)
- (2020) Juliana Cepelowicz Rajter et al. CHEST
- Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
- (2020) Na Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
- (2020) Yoriyuki Konno et al. Cell Reports
- The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies
- (2020) Zahra Payandeh et al. Expert Review of Anti-Infective Therapy
- Role of favipiravir in the treatment of COVID-19
- (2020) Shashank Joshi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials
- (2020) Desley Butters et al. INFLAMMOPHARMACOLOGY
- A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
- (2020) Sabeena Ahmed et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Transmission of Schistosoma mansoni in Yachi areas, southwestern Ethiopia: new foci
- (2019) Teshome Bekana et al. Infectious Diseases of Poverty
- Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin
- (2019) Kenneth Bentum Otabil et al. BMC INFECTIOUS DISEASES
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
- (2019) Masaaki Murakami et al. IMMUNITY
- Ivermectin treatment inhibits the replication of Porcine circovirus 2 (PCV2) in vitro and mitigates the impact of viral infection in piglets
- (2019) Xinglong Wang et al. VIRUS RESEARCH
- Ivermectin induces apoptosis of porcine trophectoderm and uterine luminal epithelial cells through loss of mitochondrial membrane potential, mitochondrial calcium ion overload, and reactive oxygen species generation
- (2019) Jin-Young Lee et al. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
- The PAK1-Stat3 Signaling Pathway Activates IL-6 Gene Transcription and Human Breast Cancer Stem Cell Formation
- (2019) Ji-Hyang Kim et al. Cancers
- Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
- (2019) Jingjing Liu et al. BIOSCIENCE REPORTS
- Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
- (2019) Marc G. Ghany et al. HEPATOLOGY
- Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology
- (2018) Satoru Eguchi et al. HYPERTENSION
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo
- (2018) Changjie Lv et al. ANTIVIRAL RESEARCH
- Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office
- (2017) Kathryn L. Anderson et al. Journal of the American Board of Family Medicine
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
- (2016) Yingying Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
- (2016) Q. Dou et al. CANCER RESEARCH
- Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells
- (2016) Chandan Seth et al. PLoS One
- Approaches to modernize the combination drug development paradigm
- (2016) Daphne Day et al. Genome Medicine
- Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex
- (2015) Yuanyuan Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- (2014) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
- (2013) Anna M. Mielech et al. VIROLOGY
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
- (2012) Kylie M. Wagstaff et al. BIOCHEMICAL JOURNAL
- Ivermectin, ‘Wonder drug’ from Japan: the human use perspective
- (2011) Andy CRUMP et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review
- (2008) Aránzazu González Canga et al. AAPS Journal
- Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice
- (2008) X. Zhang et al. INFLAMMATION RESEARCH
- Ivermectin: 25 years and still going strong
- (2007) S. Õmura INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started